logo
Share SHARE
FONT-SIZE Plus   Neg

Pfizer Unit Reaches Patent Litigation With Intelliject, Sanofi-Aventis

Mylan Inc. (MYL) and Pfizer Inc. (PFE) Thursday announced that Meridian Medical Technologies, a Pfizer subsidiary, has agreed with Intelliject and Sanofi-Aventis to resolve pending patent litigation related to Intelliject's new drug application for its epinephrine auto-injector known as e-cue.

E-cue will be manufactured and marketed by Sanofi-Aventis. Meridian manufactures EpiPen Auto-Injector and Mylan Specialty markets and distributes the product in the United States.

As per the settlement, Intelliject and Sanofi-Aventis may launch e-cue no earlier than November 15, 2012, subject to receipt of final approval from the U.S. Food and Drug Administration.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Ford Motor Co. has unveiled a scrappage scheme for UK consumers to trade in cars over seven years old, by offering 2,000 pounds discount on some new models. Under the plan, owners of any make of car or van, including petrol and diesel, that took to the road before 2010 can get the incentive. Walmart Stores Inc. announced Monday the expansion of its online grocery delivery service to two more markets, Dallas and Orlando. The deliveries will be made through a partnership with Uber. Volkswagen AG's all electric Microbus might be available in market by 2022. As per the plan it would be available first in California.
comments powered by Disqus
Follow RTT